$0.1500
Comments
Loading...
Cynata Therapeutics Analyst Ratings and Price Targets | OTC:CYYNF | Benzinga
Cynata Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cynata Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Cynata Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Cynata Therapeutics (CYYNF) stock?
There is no price target for Cynata Therapeutics
What is the most recent analyst rating for Cynata Therapeutics (CYYNF)?
There is no analyst for Cynata Therapeutics
When was the last upgrade for Cynata Therapeutics (CYYNF)?
There is no last upgrade for Cynata Therapeutics
When was the last downgrade for Cynata Therapeutics (CYYNF)?
There is no last downgrade for Cynata Therapeutics.
When is the next analyst rating going to be posted or updated for Cynata Therapeutics (CYYNF)?
There is no next analyst rating for Cynata Therapeutics.
Is the Analyst Rating Cynata Therapeutics (CYYNF) correct?
There is no next analyst rating for Cynata Therapeutics.
Browse analyst ratings and price targets on all stocks.
